Manon F. Laporte

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

New determinant of influenza hemagglutinin cleavability identified through random mutagenesis for acid-stabilizing mutations.

New determinant of influenza hemagglutinin cleavability identified through random mutagenesis for acid-stabilizing mutations.

Journal: Microbiology spectrum

Published: June 15, 2026

2-Phenylquinolines Exhibit Anti-Severe Acute Respiratory Syndrome Coronavirus-2 Activity Through the Nonstructural Protein 13 Helicase Inhibition.

2-Phenylquinolines Exhibit Anti-Severe Acute Respiratory Syndrome Coronavirus-2 Activity Through the Nonstructural Protein 13 Helicase Inhibition.

Journal: ChemMedChem

Published: November 21, 2025

Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor.

Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2025

Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro Inhibitor.

Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro Inhibitor.

Journal: Journal of medicinal chemistry

Published: June 30, 2025

High-throughput split-GFP antiviral screening assay against fusogenic paramyxoviruses.

High-throughput split-GFP antiviral screening assay against fusogenic paramyxoviruses.

Journal: Antiviral research

Published: May 27, 2025

The Combination of GS-441524 (Remdesivir) and Ribavirin Results in a Potent Antiviral Effect Against Human Parainfluenza Virus 3 Infection in Human Airway Epithelial Cell Cultures and in a Mouse Infection Model.

The Combination of GS-441524 (Remdesivir) and Ribavirin Results in a Potent Antiviral Effect Against Human Parainfluenza Virus 3 Infection in Human Airway Epithelial Cell Cultures and in a Mouse Infection Model.

Journal: Viruses

Published: January 07, 2025

Optimization of SARS-CoV-2 Mpro Inhibitors by a Structure-Based Multilevel Virtual Screening Method.

Optimization of SARS-CoV-2 Mpro Inhibitors by a Structure-Based Multilevel Virtual Screening Method.

Journal: International journal of molecular sciences

Published: December 04, 2024

Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2.

Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2.

Journal: Viruses

Published: September 05, 2024

A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology.

A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology.

Journal: Nature communications

Published: April 18, 2024

A coronavirus assembly inhibitor that targets the viral membrane protein.

A coronavirus assembly inhibitor that targets the viral membrane protein.

Journal: Nature

Published: April 06, 2024

The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity.

The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity.

Journal: Emerging microbes & infections

Published: December 19, 2023

Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters.

Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters.

Journal: bioRxiv : the preprint server for biology

Published: July 10, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026